Sanofi (company)

French pharmaceutical company

Sanofi is one of the world's leading pharmaceutical corporations.[1][2]

Sanofi works in more than a hundred countries. The company is headquartered in Paris.[3]



The company started its work on August 20, 2004 by merging Sanofi-Synthelabo and Aventis. Since then, Sanofi-Synthelabo owns 95.47% of the share capital of Aventis.[4]



Sanofi is diversified company. Sanofi's subsidiaries are

Sanofi also has several foundations:

  • Aventis Foundation[5] — charity in the field of arts, public life, science
  • Fondation Sanofi-Espoir [6] — charity in the field of health care in developing countries
  • Patient Assistance Foundation [7] — charitable program for US residents who do not have the finances to buy drugs



From October 28, 2014, the acting head of the company is Serge Weinberg.

The company's shareholders as of June 30, 2009 were:[8]

  • 9.60% of shares in Total;
  • 8.99% at L'Oreal;
  • 1.37% of the company's employees;
  • 0.76% of treasury shares;
  • 79.28% in free circulation.



The main directions of the company's work now are:[9]

  • Emerging markets;
  • Diabetes;
  • Vaccines;
  • Health products;
  • Innovative products;
  • Animal health.

Sanofi-Pasteur's vaccine division provides vaccines against the following infectious diseases: cholera, diphtheria, meningococcal infection, pertussis, tetanus, tuberculosis etc.

In 2020, Sanofi together with GlaxoSmithKline began developing a vaccine against COVID-19.[10]


  1. "Sanofi names Viehbacher as new CEO -". Retrieved 2021-04-23.
  2. Annual report form 20F 2017.
  3. "Contact - Sanofi". (in French). Retrieved 2021-04-23.
  4. "Компания «sanofi-aventis» сменила название". Аптека online. Retrieved 2021-04-23.
  5. "Aventis Foundation: Home". Retrieved 2021-04-23.
  6. "Home". Archived from the original on 2021-04-23. Retrieved 2021-04-23.
  7. "Patient Assistance Foundation". Archived from the original on 2011-12-11. Retrieved 2021-04-23.
  8. "Sanofi Shareholders". Archived from the original on 2008-11-12. Retrieved 2021-04-23.
  9. "Sanofi Strategy". Archived from the original on 2013-09-27. Retrieved 2021-04-23.
  10. "Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older - Full Text View -". Retrieved 2021-04-23.